SOURCE: Telzuit Medical Technologies, Inc.

April 17, 2007 09:00 ET

Telzuit Medical Technologies, Inc.: Operations Update

ORLANDO, FL -- (MARKET WIRE) -- April 17, 2007 --


--  Company closes two walk-in urgent care clinics
--  Mobile Imaging clinics continue to be cash flow positive
--  The Company intends to utilize all its resources to bring the
    STATPATCH Holter Monitor system to market
    
Telzuit Medical Technologies, Inc. (OTCBB: TZMT) announced that it has closed its two walk-in urgent care clinics in central Florida as of March 30, 2007. The Company expects this to result in savings of approximately $35,000 per month. Warren Stowell, CEO of Telzuit, stated that the clinics were not growing satisfactorily and further added that he believes the Company should concentrate its spending on developing the STATPATCH Holter Monitor.

Telzuit's six mobile imaging clinics continue to be cash flow positive, and the Company is aggressively marketing this product. We have upgraded the equipment in this business to state-of-the-art digital imaging ultrasound equipment.

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http/www.telzuit.com

Forward Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:
    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc.
    407-354-1222